Диссертация (1174315), страница 20
Текст из файла (страница 20)
Эндокринология.- 2005.- №6.- С. 344-353.26. Солод, Э.И. Переломы проксимального отдела бедренной кости впожилом возрасте и остеопороз / А.Ф. Лазарев, С.С. Родионова, Н.Берестовая // Врач.- 2002.- №2.- 31 с.27. Стентон, Гланц “Медико-биологическая статистика” 1999.- 459 с.28. Торопцова, Н.В.
Остеопороз: взгляд на проблему диагностика илечения // Современная ревматология.- 2009.- №3.- С. 68-71.29. Adler, R.A. Osteoporosis in men: a review // Bone Res.- 2014.- Т.2.- 8 p.30. American Academy of Family Physicians. Osteoporosis. Information fromyour family doctor. // Am. Fam. Physician. 2009.- №3.- Т.79.- P.
201-202.31. Australian Institute of Health and Welfare C. Estimating the prevalence ofosteoporosis in Australia Dr Mukesh Haikerwal A.O., David Kalisch. 2014.- 28 p.12232. Avenell, A. Vitamin D and vitamin D analogues for preventing fractures inpost-menopausal women and older men / J.C.S. Mak, D. O’Connell // Cochranedatabase. Syst. Rev.- 2014.- Т.4.- 165 p.33. Bianchi, M.L. Official positions of the International Society for ClinicalDensitometry (ISCD) on DXA evaluation in children and adolescents / S.
Baim,N.J. Bishop, C.M. Gordon // Pediatr. Nephrol.- 2010.- №1.- Т.25.-. P. 37-47.34. Bilezikian, J.P. Combination anabolic and antiresorptive therapy forosteoporosis: opening the anabolic window // Curr. Osteoporos. Rep.- 2008.- №1.Т.6.- C. 24–30.35. Binkley, N. Official positions of the International Society for ClinicalDensitometry and Executive Summary of the 2005 Position DevelopmentConference / J.P. Bilezikian, D.L. Kendler, E.S. Leib [et al.] // J Clin Densitom.2006.- Jan-Mar;9(1).- P.4-14.
DOI: 10.1016/j.jocd.2006.05.00236. Bischoff-Ferrari, H.A. How to select the doses of vitamin D in themanagement of osteoporosis // Osteoporos. Int.- 2007.-. №4.- Т.18.- P. 401-407.37. Bleicher, K. Prevalence and treatment of osteoporosis in older Australianmen: findings from the CHAMP study / V. Naganathan, R.G. Cumming, M.J.Seibel [et al.] // Med.
J. Aust.- 2010.- №7.- Т.193.- P. 387-391.38. Boonen, S. Calcium and vitamin D in the prevention and treatment ofosteoporosis - a clinical update / D. Vanderschueren, P. Haentjens, P. Lips // J.Intern. Med.- 2006.- №6.- Т.259.- P. 539-552.39. Boonen, S. Once-weekly risedronate in men with osteoporosis: results of a2-year, placebo-controlled, double-blind, multicenter study / E.S.
Orwoll, D.Wenderoth, K.J. Stoner [et al.] // J. Bone Miner. Res.- 2009.-. №4.- Т.24.- P. 719725.40. Boonen, S. Fracture risk and zoledronic acid therapy in men withosteoporosis / J.Y. Reginster, J.M. Kaufman, K. Lippuner [et al.] // N. Engl. J.Med.- 2012.- №18.- Т.367.- P. 1714-1723.41.
Burger, H. Vertebral deformities as predictors of non-vertebral fractures /P.L. van Daele, D. Algra, A. Hofman [et al.] // BMJ.- 1994.- Oct 15.- P. 991-992.12342. Burch, J. Systematic review of the use of bone turnover markers formonitoring the response to osteoporosis treatment: the secondary prevention offractures, and primary prevention of fractures in high-risk groups / S. Rice, H.Yang, A. Neilson [et al.] // Health. Technol. Assess.- 2014.- Feb;18(11).- P.
1-180.43. Braga, V. Relationship among VDR (BsmI and FokI), COL1A1, and CTRpolymorphisms with bone mass, bone turnover markers, and sex hormones in men/ A. Sangalli, G. Malerba, M. Mottes // Calcif. Tissue. Int.- 2002.- Jun;70(6). P.457-462.44. Brincat, M. The role of vitamin D in osteoporosis / J. Gambin, M. Brincat, J.Calleja-Agius // Maturitas.- 2015.- Mar;80(3). P.
329-332.45. Broulik, P.D., The effect of chronic nicotine administration on bone mineralcontent in mice / J. Jarab // Horm. Metab. Res.- 1993.- Apr; 25(4). P. 219-221.46. Campion, J.M. Osteoporosis in men / M.J. Maricic // Am. Fam. Physician.2003.- №7.- Т.67.- P. 1521-1526.47. Campisi, J. Senescent cells, tumor suppression, and organismal aging: Goodcitizens, bad neighbors // Cell.- 2005.- №4.- Т.120.- P. 513-522.48. Carey, J.J. Biochemical markers of bone turnover / A.A.
Licata, M.F.Delaney // Clinic. Rev. Bone. Miner. Metab.- 2006. №4.- P. 197-212.49. Chang, K.P. Incidence of hip and other osteoporotic fractures in elderly menand women: Dubbo Osteoporosis Epidemiology Study / J.R. Center, T.V. Nguyen,J.A. Eisman // J. Bone. Miner. Res.- 2004.- Apr; 19(4).- P. 532-536.50. Chopin, F. Prognostic interest of bone turnover markers in the managementof postmenopausal osteoporosis / E. Biver, T. Funck-Brentano, B. Bouvard // J.Bone. Spine.- 2012.- Jan;79(1).- P. 26-31.51.
Clarke, B.L. Physiology of bone loss / S. Khosla // Radiol. Clin. North. Am.2010.- №3.- Т.48.- P. 483-495.52. Compston, J. UK clinical guideline for the prevention and treatment ofosteoporosis / A. Cooper, C. Cooper, N. Gittoes [et al.] // Arch. Osteoporos.2017.- Dec;12(1). 43 p.12453. Cosman, F. National Osteoporosis Foundation. Clinician's Guide toPrevention and Treatment of Osteoporosis / S.J. de Beur, M.S. LeBoff, E.M.Lewiecki [et al.] // Osteoporos Int.- 2014.- Oct;25(10).- P. 2359-2381.54. Dambacher, M.A. Highly precise peripheral quantitative computedtomography for the evaluation of bone density, loss of bone density and structures.Consequences for prophylaxis and treatment / M. Neff, R.
Kissling, L. Qin //Drugs. Aging.- 1998.- 12 Suppl 1.- P. 15-24.55. Darelid, A. Bone Turnover Markers Predict Bone Mass Development inYoung Adult Men: A Five-Year Longitudinal Study / M. Nilsson, J.M. Kindblom,D. Mellström [et al.] // J. Clin. Endocrinol. Metab.- 2015.- 100(4).- P. 1460-1468.56. Dai, Z. Bone turnover biomarkers and risk of osteoporotic hip fracture in anAsian population / R. Wang, L.W.
Ang, J.M. Yuan // Bone.- 2016.- 83. P. 171-177.57. D’Amelio, P. Bone and bone marrow pro-osteoclastogenic cytokines are upregulated in osteoporosis fragility fractures / I. Roato, L. D'Amico, L. Veneziano[et al.] // Osteoporos. Int.- 2011.- №11.- Т.22.- P. 2869-2877.58. D'Amelio, P. Effect of intermittent PTH treatment on plasma glucose inosteoporosis: A randomized trial / F. Sassi, I.
Buondonno, E. Spertino [et al.] //Bone.- 2015.- Jul;76.- P. 177-184.59. Ding, Z. Impact of Age, Gender, and Body Composition on Bone Quality inan Adult Population From the Middle Areas of China / Y. Chen, Y. Xu, X. Zhou //J. Clin. Densitom.- 2018.- Jan-Mar;21(1).- P. 83-90.60. Donaldson, M.G.
Estimates of the proportion of older white men who wouldbe recommended for pharmacologic treatment by the new US NationalOsteoporosis Foundation guidelines / P.M. Cawthon, L.Y. Lui, J.T. Schousboe [etal.] // J. Bone. Miner. Res.- 2010.-. №7.- Т.25.- P. 1506-1511.61. Dhanwal, D.K. Incidence of hip fracture in Rohtak district, North India / R.Siwach, V.
Dixit, A. Mithal [et al.] // Arch Osteoporos.- 2013.- 8:135.- P. 1-5.62.Dukas,L.Alfacalcidolreducesthenumberoffallersinacommunitydwelling elderly population with a minimum calcium intake of more125than 500 mg daily / H.A. Bischoff, L.S. Lindpaintner, E. Schacht [et al.] // J. Am.Geriatr. Soc.- 2004.- Feb;52(2). P. 230-236.63. Ebeling, P.R. Clinical practice. Osteoporosis in men // N. Engl. J. Med.2008.- №14.- Т.358.- 1474-1482.64. Emaus, N.
Impacts of body mass index, physical activity, and smoking onfemoral bone loss: the Tromsø study / T. Wilsgaard, L.A. Ahmed // J. Bone.Miner. Res.- 2014.- №9.- Т.29.- P. 2080-2089.65. Endo, I. Deletion of vitamin D receptor gene in mice results in abnormalskeletal muscle development with deregulated expression of myoregulatorytranscription factors / D. Inoue, T. Mitsui, Y. Umaki [et al.] // Endocrinology.2003.- Dec;144(12).- P. 5138-5144.66. Estrada, K. Genome-wide meta-analysis identifies 56 bone mineral densityloci and reveals 14 loci associated with risk of fracture / U.
Styrkarsdottir, E.Evangelou, Y.H. Hsu [et al.] // Nat. Genet.- 2012.- №5.- Т.44.- P. 491-501.67. Feldstein, A.C. The near absence of osteoporosis treatment in older menwith fractures / G. Nichols, E. Orwoll, P.J. Elmer [et al.] // Osteoporos. Int.- 2005.№8.- Т.16.- P. 953-962.68. Finkelstein, J.S. Gonadal steroid-dependent effects on bone turnover andbone mineral density in men / H. Lee, B.Z. Leder, S.A.
Burnett-Bowie [et al.] // J.Clin. Invest.- 2016.- Mar 1;126(3).- P. 1114-1125.69. Frost, M.L. Dissociation between global markers of bone formation anddirect measurement of spinal bone formation in osteoporosis / I. Fogelman, G.M.Blake, P.K. Marsden [et al.] // J. Bone. Miner. Res.- 2004.- Nov; 19(11).- P. 17971804.70. Franke, J. H. Runge: Osteoporosе.
Diagnose, Differetialdiagnose undTherapie Veb. verlag volk and Gesundheit // Berlin.- 1987.- 25 p.71. Gallagher, J.C. Combination treatment with estrogen and calcitriol in theprevention of age-related bone loss / S.E. Fowler, J.R. Detter, S.S. Sherman // J.Clin. Endocrinol. Metab.- 2001.- Aug;86(8).- P. 3618-3628.12672. Garnero, P.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
